These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16096429)

  • 1. A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.
    Okrój M; Kamysz W; Slominska EM; Mysliwski A; Bigda J
    Anticancer Drugs; 2005 Sep; 16(8):817-23. PubMed ID: 16096429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.
    Hines J; Ju R; Dutschman GE; Cheng YC; Crews CM
    J Pharmacol Exp Ther; 2010 Sep; 334(3):729-38. PubMed ID: 20571059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNP-470 is an effective antimicrosporidial agent.
    Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
    J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical pattern of cell death in B16F10 melanoma cells treated with TNP-470.
    Okrój M; Stawikowska D; Słomińska EM; Myśliwski A; Bigda J
    Cell Mol Biol Lett; 2006; 11(3):384-95. PubMed ID: 16874459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.
    Zhang Y; Griffith EC; Sage J; Jacks T; Liu JO
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6427-32. PubMed ID: 10841547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.
    Taki T; Ohnishi T; Arita N; Hiraga S; Saitoh Y; Izumoto S; Mori K; Hayakawa T
    J Neurooncol; 1994; 19(3):251-8. PubMed ID: 7807176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
    Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
    Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia.
    Kria L; Ohira A; Amemiya T
    Curr Eye Res; 1998 Oct; 17(10):986-93. PubMed ID: 9788301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer.
    Nahari D; Satchi-Fainaro R; Chen M; Mitchell I; Task LB; Liu Z; Kihneman J; Carroll AB; Terada LS; Nwariaku FE
    Mol Cancer Ther; 2007 Apr; 6(4):1329-37. PubMed ID: 17431111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro.
    Norén-Nyström U; Eriksson M; Eriksson B; Roos G; Bergh A; Holmberg D
    Exp Hematol; 2003 Feb; 31(2):143-9. PubMed ID: 12591279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
    Turk BE; Su Z; Liu JO
    Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNP-470 promotes initial vascular sprouting in xenograft tumors.
    Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
    Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.
    Morita T; Shinohara N; Tokue A
    Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
    Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
    Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
    Murata R; Nishimura Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.
    Ogawa H; Sato Y; Kondo M; Takahashi N; Oshima T; Sasaki F; Une Y; Nishihira J; Todo S
    Oncol Rep; 2000; 7(3):467-72. PubMed ID: 10767353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2.
    Koyama H; Nishizawa Y; Hosoi M; Fukumoto S; Kogawa K; Shioi A; Morii H
    Circ Res; 1996 Oct; 79(4):757-64. PubMed ID: 8831499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.